Industry
Biotechnology
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 29, 2024 | 3:31 pm
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 1:47 pm
Portfolio Pulse from Benzinga Newsdesk
August 09, 2024 | 3:23 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 8:39 pm
Portfolio Pulse from Benzinga Newsdesk
July 01, 2024 | 8:11 pm
Portfolio Pulse from Benzinga Newsdesk
May 30, 2024 | 12:53 pm
Portfolio Pulse from Benzinga Newsdesk
May 03, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 03, 2024 | 3:59 pm
Portfolio Pulse from Benzinga Newsdesk
May 02, 2024 | 9:40 pm
Portfolio Pulse from Benzinga Newsdesk
May 02, 2024 | 9:29 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.